Oslo Pensjonsforsikring AS Makes New $467,000 Investment in Kenvue Inc. $KVUE

Oslo Pensjonsforsikring AS bought a new stake in Kenvue Inc. (NYSE:KVUE) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 27,075 shares of the company’s stock, valued at approximately $467,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Commerzbank Aktiengesellschaft FI lifted its position in shares of Kenvue by 1.2% during the 1st quarter. Commerzbank Aktiengesellschaft FI now owns 79,607 shares of the company’s stock worth $1,372,000 after buying an additional 939 shares during the last quarter. Meeder Advisory Services Inc. grew its position in Kenvue by 52.9% in the first quarter. Meeder Advisory Services Inc. now owns 37,024 shares of the company’s stock valued at $638,000 after acquiring an additional 12,806 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Kenvue by 0.9% in the first quarter. Dimensional Fund Advisors LP now owns 22,270,175 shares of the company’s stock valued at $383,938,000 after acquiring an additional 196,981 shares during the last quarter. Parallel Advisors LLC grew its position in Kenvue by 7.3% in the first quarter. Parallel Advisors LLC now owns 20,009 shares of the company’s stock valued at $345,000 after acquiring an additional 1,365 shares during the last quarter. Finally, KBC Group NV raised its stake in Kenvue by 98.3% during the first quarter. KBC Group NV now owns 977,811 shares of the company’s stock worth $16,858,000 after acquiring an additional 484,695 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

KVUE has been the subject of a number of research reports. Citigroup dropped their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. UBS Group lifted their price target on shares of Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a report on Thursday, July 16th. Wall Street Zen upgraded shares of Kenvue to a “buy” rating in a research report on Sunday, July 12th. Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Finally, Barclays raised their target price on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Tuesday. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $19.58.

Kenvue Price Performance

Kenvue stock opened at $18.98 on Wednesday. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $36.43 billion, a PE ratio of 22.32, a P/E/G ratio of 1.44 and a beta of 0.47. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $22.87. The stock has a 50-day moving average price of $18.26 and a two-hundred day moving average price of $17.88.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. During the same period in the previous year, the business posted $0.24 earnings per share. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. Analysts expect that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were given a dividend of $0.2075 per share. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.4%. Kenvue’s dividend payout ratio (DPR) is currently 97.65%.

Insiders Place Their Bets

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.59% of the stock is owned by insiders.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.